Middle East conflict strains cold‑chain routes

Fighting in the Middle East has disrupted shipping corridors and forced reroutes that are delaying temperature‑sensitive medicines and creating stock bottlenecks in clinics worldwide. Companies are already rerouting shipments and governments are stepping in locally, which raises short‑term risks for biologics and any product reliant on intact cold chains. (pharmexec.com) (kuow.org)

The weak point in the drug supply chain is not the factory. It is the handoff. A biologic can survive a long trip only if every airport transfer, warehouse stop, customs delay, and truck ride stays inside a narrow temperature band. That system has been jolted by the widening Middle East war. Airspace closures at major Gulf hubs including Dubai, Abu Dhabi, and Doha have forced pharmaceutical companies to reroute refrigerated shipments of cancer drugs, vaccines, and other biologics through longer, less practiced corridors. Sea freight is no easy fallback because the Strait of Hormuz has also been disrupted, cutting off one of the region’s main maritime chokepoints (pharmexec.com). That matters because the Gulf is not some regional side road. It is one of the world’s switching yards for temperature-sensitive medicine. Dubai and Doha connect Europe to Asia and Africa, and carriers based there built specialized pharma handling around that role. Emirates says its Dubai operation includes a dedicated GDP-certified pharma hub for temperature-sensitive cargo, and Reuters reporting cited by multiple outlets says more than a fifth of global air cargo is exposed to disruption in the region (skycargo.com) (whtc.com). Once those hubs falter, the damage spreads fast. Drugmakers have been diverting shipments through Jeddah and Riyadh in Saudi Arabia, through Istanbul, and through Oman, then trucking products overland to final markets. That keeps some supply moving, but it also adds hours, border crossings, and extra handling steps. Each one raises the odds of a temperature excursion. The products at highest risk are the ones with the least slack: short-shelf-life refrigerated medicines, especially oncology monoclonal antibodies, where a missed delivery can mean a missed treatment cycle rather than a mere inconvenience (pharmexec.com). The humanitarian system is running into the same wall, only with less room to absorb the shock. Reuters reported on March 26 that the World Health Organization’s aid shipments from its Dubai hub were at one point completely frozen as air, sea, and land routes were restricted. The agency has since shifted to long overland workarounds, with UAE support for trucking insulin and emergency kits to Lebanon via Saudi Arabia, Jordan, and Syria, and for charter flights to places such as Kabul. The price of those detours is simple: higher fuel bills, longer lead times, and a backlog in Dubai that has still not fully cleared (usnews.com). That backlog is already turning into empty shelves far from the Gulf. KUOW, drawing on AP reporting, described medical supplies stranded in Dubai while clinics in Africa and Asia faced shortages. Save the Children said the conflict has delayed medical shipments for at least 410,000 children in three countries. One consignment bound for Sudan, including antibiotics, antimalarials, pain medicines, vitamins, and pediatric injectables, is stuck in Dubai and threatens supplies at more than 90 primary health facilities. Another shipment for Yemen is also stuck there and, for the first time, will be moved by road at roughly double the transport cost (kuow.org) (savethechildren.org). The hidden problem is that delays do not only hit finished drugs. They also hit the dull, irreplaceable parts that make modern medicine usable at all. PharmExec reports that constraints now extend to vial stoppers and IV-bag plastics, which means a shipment can fail even when the active ingredient exists and the factory is running. Air-freight markets are tightening at the same time. Industry reporting says the conflict has cut capacity and pushed rates higher, which makes every replacement route more expensive and every late shipment harder to recover. A cold chain can bend, but it does not bend for free (pharmexec.com) (stattimes.com). That is why the most revealing detail in this story is not a missile strike or a freight rate. It is a box of medicine waiting in the wrong warehouse. Save the Children says one Sudan shipment may now have to go by road across Jeddah and then by sea to Port Sudan, adding $1,000 to $2,000 per container. In Afghanistan, the group says nutrition supplies that would have moved through Iran now have to fly in for more than $240,000, which is more than the supplies themselves are worth (savethechildren.org).

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.